Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies.

Shah VN, Agesen RM, Bardtrum L, Christiansen E, Snaith J, Greenfield JR. Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies. J Diabetes Sci Technol. 2025 Mar; 19(2):321-331.

View in: PubMed

subject areas

Adult
Blood Glucose
Diabetes Mellitus, Type 1
Female
Humans
Hypoglycemic Agents
Insulin
Liraglutide
Male
Middle Aged
Treatment Outcome
Young Adult

authors with profiles

Viralkumar N Shah

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium